|
HY-P74742-10ug
|
MedChemexpress LLC
|
MST1/STK4, Human (sf9, His)
|
|
|
|
|
HY-P74742-50ug
|
MedChemexpress LLC
|
MST1/STK4, Human (sf9, His)
|
|
|
|
|
HY-P1240B-1mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (acetate)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1240B-10mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (acetate)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1240B-5mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (acetate)
|
|
COVID-19-immunoregulation
|
|
|
HY-P1240A-1mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1240A-10mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-P1240A-5mg
|
MedChemexpress LLC
|
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), mouse, rat (TFA)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-141510-10mg
|
MedChemexpress LLC
|
myo-Inositol trispyrophosphate (hexasodium) [CAS 23103-35-7]
|
|
Cancer-programmed cell death
|
|
|
HY-141510-100mg
|
MedChemexpress LLC
|
myo-Inositol trispyrophosphate (hexasodium) [CAS 23103-35-7]
|
|
Cancer-programmed cell death
|
|
|
HY-141510-25mg
|
MedChemexpress LLC
|
myo-Inositol trispyrophosphate (hexasodium) [CAS 23103-35-7]
|
|
Cancer-programmed cell death
|
|
|
HY-141510-5mg
|
MedChemexpress LLC
|
myo-Inositol trispyrophosphate (hexasodium) [CAS 23103-35-7]
|
|
Cancer-programmed cell death
|
|
|
HY-141510-50mg
|
MedChemexpress LLC
|
myo-Inositol trispyrophosphate (hexasodium) [CAS 23103-35-7]
|
|
Cancer-programmed cell death
|
|
|
HY-P74736-10ug
|
MedChemexpress LLC
|
NBL1, Human (HEK293, His)
|
|
|
|
|
HY-P74736-100ug
|
MedChemexpress LLC
|
NBL1, Human (HEK293, His)
|
|
|
|
|
HY-P74736-5ug
|
MedChemexpress LLC
|
NBL1, Human (HEK293, His)
|
|
|
|
|
HY-P74736-50ug
|
MedChemexpress LLC
|
NBL1, Human (HEK293, His)
|
|
|
|
|
HY-P9964-1mg
|
MedChemexpress LLC
|
NecituMu mab [CAS 906805-06-9]
|
|
|
|
|
HY-P9964-10mg
|
MedChemexpress LLC
|
NecituMu mab [CAS 906805-06-9]
|
|
|
|
|
HY-P9964-5mg
|
MedChemexpress LLC
|
NecituMu mab [CAS 906805-06-9]
|
|
|
|
|
HY-121954-1mg
|
MedChemexpress LLC
|
Necrostatin-1 (inactive control) [CAS 64419-92-7]
|
|
|
|
|
HY-P75936-10ug
|
MedChemexpress LLC
|
NELL2, Human (sf9, His)
|
|
|
|
|
HY-P75936-5ug
|
MedChemexpress LLC
|
NELL2, Human (sf9, His)
|
|
|
|
|
HY-P75936-50ug
|
MedChemexpress LLC
|
NELL2, Human (sf9, His)
|
|
|
|
|
HY-N0478-10mg
|
MedChemexpress LLC
|
Neoline [CAS 466-26-2]
|
|
Neuroscience-Neuromodulation
|
|
